ArticleIJU case reports2026
A Case of a Rare Testicular Tumor With Synchronous Malignancy.
Article in IJU case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Leydig cell tumors are an uncommon malignancy accounting for 1%-2% of all testicular tumors. Synchronous, non-testicular malignancy is a rare finding. Case Presentation: A 51-year-old male presented with left testicular pain, and a scrotal ultrasound revealed a testicular mass. Radical orchiectomy histology demonstrated a Leydig cell tumor. Staging imaging depicted a large anterior mediastinal mass, with resection demonstrating a thymoma. Conclusion: With the increasing incidence of testicular cancer, it is important to recognize the disease's signs and symptoms. Leydig cell cancer has the potential for metastatic disease, and staging imaging is imperative, with consideration for potential metastatic disease versus synchronous malignancy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.